Tag: Breast Cancer
-

Young Women and Breast Cancer: Fertility and Screening
Understanding fertility and breast cancer treatment In a recent interview, Dr. Anita Wolfer of the Geneva University Hospitals (HUG) shed light on how breast cancer treatment can intersect with a patient’s desire to have children. Treatments that target hormonal pathways can impact fertility, but for younger women, a carefully supervised pause in therapy—about two years…
-

Anita Wolfer on Fertility and Breast Cancer: 74% of Young Women Have Had Children Post-Treatment
Overview: Fertility and breast cancer treatment In a discussion on La Matinale, Dr. Anita Wolfer, a senior oncologist at the Geneva University Hospitals (HUG), explains a key nuance for younger women diagnosed with breast cancer: therapies that target hormones can suppress fertility. Yet, for those who wish to start a family, a carefully monitored pause…
-

Breast Cancer in Portugal: Current Realities and Hope for the Future
Overview: the burden of breast cancer in Portugal Breast cancer is the most common cancer among women in Portugal. On average, 13 new cases are diagnosed each day, and four women lose their lives daily to the disease. These numbers reflect not only the scale of the challenge but also the urgent need to invest…
-

Breast Cancer Fertility and Screening for Young Women: Insights from Dr. Anita Wolfer
Fertility and breast cancer: navigating treatment and life plans In a recent discussion on La Matinale, Dr. Anita Wolfer, associate physician in the Oncology Department at Geneva University Hospitals (HUG), explains how breast cancer treatment—often hormone-based—can affect a patient’s ability to have children. For younger women who wish to conceive, a temporary pause in treatment…
-

Breast Cancer in Portugal: Current Realities and Outlook
Introduction: a pressing health reality in Portugal Breast cancer is the most common cancer affecting women in Portugal. On average, 13 new cases are diagnosed each day, and four women lose their lives to the disease daily. These figures reflect not only the scale of the challenge but also the urgent need for investment in…
-

Breast Cancer in Portugal: 45-year Screening and Current Realities
The current reality of breast cancer in Portugal Breast cancer is the most common cancer among women in Portugal. On average, 13 new cases are diagnosed every day, and four women die from the disease daily. These figures reveal not only the scale of the challenge but also the urgent need to invest in prevention,…
-

Street Nipples: Pavement Art Aims to Boost Early Breast Cancer Detection in the UK
Street Nipples: pavements become a platform for life-saving awareness Breast Cancer UK has launched an innovative campaign called Street Nipples, transforming city pavements into intentional reminders about the importance of early breast cancer detection. Through playful chalk drawings and street-level messaging, the initiative seeks to spark conversations that may lead to sooner checks and potentially…
-

Street Nipples Campaign: Early Breast Cancer Detection on UK Streets
Global context: cancer and early detection According to the World Health Organization, cancer is the second leading cause of death worldwide, and many lives are lost when the disease is not diagnosed early. Street Nipples tackles this hard truth by turning sidewalks into everyday prompts for timely screening and breast checks, transforming public space into…
-

Street Nipples: Turning Pavement Art into Early Breast Cancer Detection Awareness
What is Street Nipples? Breast Cancer UK has launched Street Nipples, an audacious pavement-art project designed to spark conversations about breast cancer and the critical role of early detection. The initiative paints messages on streets to remind passersby to check their breasts regularly and to seek professional advice if something feels off. The project is…
-

Could a Blood Test Screen for Breast Cancer? AI-Driven Early Detection in Young Women
The Promise of a Blood Test for Breast Cancer Across Canada, researchers are pursuing a simple, noninvasive blood test as a potential supplement to conventional screening for breast cancer. Led by a team at the Centre de recherche du Centre hospitalier de l’Université de Montréal, the work focuses on using a blood-based approach to detect…
